Empowering the board with international investment & clinical experience
Cerebriu A/S, Cerebriu, a provider of artificial intelligence (AI) solutions for automating radiology workflows today announced the appointment of Jonathan P. Gertler, MD as the new Member of the Board for scaling up in the US market.
Dr. Jonathan P. Gertler, is one of the Managing Directors at BioVentures Investors MedTech Funds, and also Managing Partner and CEO of Back Bay Life Science Advisors, both based in Boston. He brings to Cerebriu over 30 years of clinical and scientific experience, and extensive advisory work within healthcare, both private and public sector, and is a founder of several life science companies. Dr. Gertler was an Associate Professor of Surgery at Harvard Medical School and the Massachusetts General Hospital (MGH), and was trained at Columbia, Yale and the MGH.
“We are proud to have Dr. Gertler in our Board of Directors,” said Robert Lauritzen, Chief Executive Officer at Cerebriu. “Dr. Gertler’s expertise within life science spanning business management, clinical practice and venture investing will contribute significantly to Cerebriu’s journey to automate radiology workflows on a global scale.”
“I have a life-long passion for healthcare innovation and development and find the Nordics a compelling region for ground-breaking technologies and businesses within this space,” said Dr. Jonathan Gertler. “My knowledge of Cerebriu goes back several years starting from their very early stages. I believe their team and innovations for radiology are transformative, and I’m truly excited about joining the board as an independent director to support the growth phase of the company.”
À propos de Cerebriu
Cerebriu automate radiology workflows for improved throughput and broader access of diagnostic imaging. Our first product supports brain MRI workflows.
For more information, please reach out to Oded firstname.lastname@example.org